Effect of a prioritization score on the inter-hospital transfer time management of severe COVID-19 patients: a quasi-experimental intervention study.

COVID-19 critical illness dispatch centre emergency care triage management

Journal

International journal for quality in health care : journal of the International Society for Quality in Health Care
ISSN: 1464-3677
Titre abrégé: Int J Qual Health Care
Pays: England
ID NLM: 9434628

Informations de publication

Date de publication:
28 Mar 2022
Historique:
received: 04 10 2021
revised: 21 02 2022
accepted: 12 03 2022
pubmed: 16 3 2022
medline: 1 4 2022
entrez: 15 3 2022
Statut: ppublish

Résumé

The overburdening of the healthcare system during the coronavirus disease 19 (COVID-19) pandemic is driving the need to create new tools to improve the management of inter-hospital transport for patients with a severe COVID-19 infection. The aim of this study was to analyse the usefulness of the application of a prioritization score (IHTCOVID-19) for inter-hospital transfer of patients with COVID-19 infection. The study has a quasi-experimental design and was conducted on the Medical Emergency System, the pre-hospital emergency department of the public company belonging to the Autonomous Government of Catalonia that manages urgent healthcare in the region. Patients with a severe COVID-19 infection requiring inter-hospital transport were consecutively included. The pre-intervention period was from 1 to 31 March 2020, and the intervention period with the IHTCOVID-19 score was from 1 to 30 April 2020 (from 8 am to 8 pm). The prioritization score comprises four priority categories, with Priority 0 being the highest and Priority 3 being the lowest. Inter-hospital transfer (IHT) management times (alert-assignment time, resource management time and total central management time) and their variability were evaluated according to whether or not the IHTCOVID-19 score was applied. A total of 344 IHTs were included: 189 (54.9%) in the pre-intervention period and 155 (45.1%) in the post-intervention period. The majority of patients were male and the most frequent age range was between 50 and 70 years. According to the IHTCOVID-19 score, 12 (3.5%) transfers were classified as Priority 0, 66 (19.4%) as Priority 1, 247 (71.8%) as Priority 2 and 19 (5.6%) as Priority 3. Overall, with the application of the IHTCOVID-19 score, there was a significant reduction in total central management time [from 112.4 (inter-quartile range (IQR) 281.3) to 89.8 min (IQR 154.9); P = 0.012]. This significant reduction was observed in Priority 0 patients [286.2 (IQR 218.5) to 42.0 min (IQR 58); P = 0.018] and Priority 1 patients [130.3 (IQR 297.3) to 75.4 min (IQR 91.1); P = 0.034]. After applying the IHTCOVID-19 score, the average time of the process decreased by 22.6 min, and variability was reduced from 618.1 to 324.0 min. The application of the IHTCOVID-19 score in patients with a severe COVID-19 infection reduces IHT management times and variability.

Sections du résumé

BACKGROUND BACKGROUND
The overburdening of the healthcare system during the coronavirus disease 19 (COVID-19) pandemic is driving the need to create new tools to improve the management of inter-hospital transport for patients with a severe COVID-19 infection.
OBJECTIVE OBJECTIVE
The aim of this study was to analyse the usefulness of the application of a prioritization score (IHTCOVID-19) for inter-hospital transfer of patients with COVID-19 infection.
METHODS METHODS
The study has a quasi-experimental design and was conducted on the Medical Emergency System, the pre-hospital emergency department of the public company belonging to the Autonomous Government of Catalonia that manages urgent healthcare in the region. Patients with a severe COVID-19 infection requiring inter-hospital transport were consecutively included. The pre-intervention period was from 1 to 31 March 2020, and the intervention period with the IHTCOVID-19 score was from 1 to 30 April 2020 (from 8 am to 8 pm). The prioritization score comprises four priority categories, with Priority 0 being the highest and Priority 3 being the lowest. Inter-hospital transfer (IHT) management times (alert-assignment time, resource management time and total central management time) and their variability were evaluated according to whether or not the IHTCOVID-19 score was applied.
RESULTS RESULTS
A total of 344 IHTs were included: 189 (54.9%) in the pre-intervention period and 155 (45.1%) in the post-intervention period. The majority of patients were male and the most frequent age range was between 50 and 70 years. According to the IHTCOVID-19 score, 12 (3.5%) transfers were classified as Priority 0, 66 (19.4%) as Priority 1, 247 (71.8%) as Priority 2 and 19 (5.6%) as Priority 3. Overall, with the application of the IHTCOVID-19 score, there was a significant reduction in total central management time [from 112.4 (inter-quartile range (IQR) 281.3) to 89.8 min (IQR 154.9); P = 0.012]. This significant reduction was observed in Priority 0 patients [286.2 (IQR 218.5) to 42.0 min (IQR 58); P = 0.018] and Priority 1 patients [130.3 (IQR 297.3) to 75.4 min (IQR 91.1); P = 0.034]. After applying the IHTCOVID-19 score, the average time of the process decreased by 22.6 min, and variability was reduced from 618.1 to 324.0 min.
CONCLUSION CONCLUSIONS
The application of the IHTCOVID-19 score in patients with a severe COVID-19 infection reduces IHT management times and variability.

Identifiants

pubmed: 35289365
pii: 6548674
doi: 10.1093/intqhc/mzac011
pmc: PMC8992311
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of International Society for Quality in Health Care. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

J Emerg Med. 2020 Feb;58(2):280-289
pubmed: 31761462
Scand J Trauma Resusc Emerg Med. 2021 Jun 4;29(1):78
pubmed: 34088335
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Ann Ist Super Sanita. 2021 Apr-Jun;57(2):113-120
pubmed: 34132207
JAMA. 2007 Nov 28;298(20):2371-80
pubmed: 17982184
BMJ. 2020 May 22;369:m1966
pubmed: 32444366
Emergencias. 2021 Abr;33(2):151-153
pubmed: 33750060
Crit Care Med. 2007 Apr;35(4):1003-11
pubmed: 17334242
Rev Med Virol. 2021 Jan;31(1):1-10
pubmed: 32845042
Chest. 2014 Oct;146(4 Suppl):e44S-60S
pubmed: 25144509
Am J Respir Crit Care Med. 2021 Feb 1;203(3):287-295
pubmed: 33522881
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Emergencias. 2020 Ago;32(4):301-302
pubmed: 32692016
Med Intensiva (Engl Ed). 2020 Oct;44(7):439-445
pubmed: 32402532
N Engl J Med. 2020 May 14;382(20):1873-1875
pubmed: 32187459
N Engl J Med. 2006 Jan 26;354(4):366-78
pubmed: 16436768
Prehosp Emerg Care. 2014 Apr-Jun;18(2):282-9
pubmed: 24401167
Emergencias. 2021 Aug;33(4):265-272
pubmed: 34251139
PLoS One. 2020 Jul 23;15(7):e0236240
pubmed: 32702044
JAMA Netw Open. 2020 Jun 1;3(6):e2012606
pubmed: 32558916
Nat Med. 2020 Aug;26(8):1212-1217
pubmed: 32546823
Eur J Trauma Emerg Surg. 2020 Apr;46(2):425-433
pubmed: 30406394
Front Public Health. 2018 Jun 11;6:149
pubmed: 29942800
J Am Med Dir Assoc. 2020 Jul;21(7):915-918
pubmed: 32674819
Med Care. 2009 Jul;47(7):787-93
pubmed: 19536030
Heart Lung Circ. 2020 Jul;29(7):e88-e93
pubmed: 32487432

Auteurs

Silvia Solà-Muñoz (S)

Area of Research and Development, Clinical Department, Sistema d'Emergències Mèdiques de Catalunya, C. Pablo Iglesias 101-155, L'Hospitalet de Llobregat, Barcelona 08908, Spain.
Sociedad Española de Medicina de Urgencias y Emergencias, Red de Investigación de Emergencias Prehospitalarias RINVEMER, nuñez de balboa 116 3° office 9, Madrid 28020, Spain.

Youcef Azeli (Y)

Area of Research and Development, Clinical Department, Sistema d'Emergències Mèdiques de Catalunya, C. Pablo Iglesias 101-155, L'Hospitalet de Llobregat, Barcelona 08908, Spain.
Sociedad Española de Medicina de Urgencias y Emergencias, Red de Investigación de Emergencias Prehospitalarias RINVEMER, nuñez de balboa 116 3° office 9, Madrid 28020, Spain.
Hospital Universitari Sant Joan de Reus, Institut d'Investigació Sanitària Pere Virgili (IISPV), Avda, Josep Laporte, 2 Planta 0 - E2 color taronja, Reus, Tarragona 43204, Spain.

Josep Trenado (J)

Area of Research and Development, Clinical Department, Sistema d'Emergències Mèdiques de Catalunya, C. Pablo Iglesias 101-155, L'Hospitalet de Llobregat, Barcelona 08908, Spain.
Intensive Care Unit, Hospital Universitari Mutua de Terrassa, Plaça del Doctor Robert, 5, Terrassa, Barcelona 08221, Spain.

Xavier Jiménez (X)

Area of Research and Development, Clinical Department, Sistema d'Emergències Mèdiques de Catalunya, C. Pablo Iglesias 101-155, L'Hospitalet de Llobregat, Barcelona 08908, Spain.
Sociedad Española de Medicina de Urgencias y Emergencias, Red de Investigación de Emergencias Prehospitalarias RINVEMER, nuñez de balboa 116 3° office 9, Madrid 28020, Spain.

Roger Bisbal (R)

Area of Research and Development, Clinical Department, Sistema d'Emergències Mèdiques de Catalunya, C. Pablo Iglesias 101-155, L'Hospitalet de Llobregat, Barcelona 08908, Spain.

Àngels López (À)

Area of Research and Development, Clinical Department, Sistema d'Emergències Mèdiques de Catalunya, C. Pablo Iglesias 101-155, L'Hospitalet de Llobregat, Barcelona 08908, Spain.

Jorge Morales (J)

Area of Research and Development, Clinical Department, Sistema d'Emergències Mèdiques de Catalunya, C. Pablo Iglesias 101-155, L'Hospitalet de Llobregat, Barcelona 08908, Spain.

Xaime García (X)

Area of Research and Development, Clinical Department, Sistema d'Emergències Mèdiques de Catalunya, C. Pablo Iglesias 101-155, L'Hospitalet de Llobregat, Barcelona 08908, Spain.

Bernat Sánchez (B)

Area of Research and Development, Clinical Department, Sistema d'Emergències Mèdiques de Catalunya, C. Pablo Iglesias 101-155, L'Hospitalet de Llobregat, Barcelona 08908, Spain.

José Fernández (J)

Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Av. Colom 16-20, Tortosa, Tarragona 43500, Spain.
Unidat de Recerca, Gerència Territorial Terres de l´Ebre, Institut Català de la Salut, Ctra. de la Simpàtica, 44, Tortosa, Tarragona 43500, Spain.

Maria Ángeles Soto (MÁ)

Area of Research and Development, Clinical Department, Sistema d'Emergències Mèdiques de Catalunya, C. Pablo Iglesias 101-155, L'Hospitalet de Llobregat, Barcelona 08908, Spain.

Yolanda Ferreres (Y)

Area of Research and Development, Clinical Department, Sistema d'Emergències Mèdiques de Catalunya, C. Pablo Iglesias 101-155, L'Hospitalet de Llobregat, Barcelona 08908, Spain.

Cristina Cantero (C)

Area of Research and Development, Clinical Department, Sistema d'Emergències Mèdiques de Catalunya, C. Pablo Iglesias 101-155, L'Hospitalet de Llobregat, Barcelona 08908, Spain.

Javier Jacob (J)

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Universitat de Barcelona, Carrer de la Feixa Llarga, s/n, Barcelona 08907, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH